Children's Hospital Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Hospital Los Angeles sits in the top decile of US sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count).
Children's Hospital Los Angeles: 119 sponsored US clinical trials, 35 recruiting.
Children's Hospital Los Angeles sponsors 119 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 62 completed. 8 of these trials are in Phase 3-4 (later-stage) and 20 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 4 trials.
Top-decile sponsor footprint
Children's Hospital Los Angeles ranks in the top decile of sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
62 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
119 total, page 1 of 3
Final Prototype Refinement of Adaptive Cell Phone Support
NCT07084155
Virtual Reality (VR) for Interventional Radiology (IR) Procedures
NCT07427862
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
NCT07213908
Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
NCT07023367
Implementation of Team Clinic for Type 2 Diabetes (TCT2)
NCT06923046
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
NCT07073612
Type 2 Continuous Glucose Monitoring Academy
NCT06516640
Health Care Transition Readiness Short-Form Video Intervention
NCT06842576
Bridge the Gap (BTG) - Black Youth Group
NCT06880809
CGM Academy for Youth With Type 1 Diabetes
NCT06408207
Maralixibat in Patients With Cystic Fibrosis and Constipation
NCT06413368
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
NCT05685368
Pediatric Positive End Expiratory Pressure (PEEP) Titration Using Electrical Impedence Tomography (EIT)
NCT06684119
Adaptive Rock Climbing
NCT06507072
Designing Team Clinic for Youth With Type 2 Diabetes
NCT06658743
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
NCT06690801
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
NCT06526260
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities
NCT06783101
Self-Concept Reinforcement for Early School Readiness
NCT06084910
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
NCT06096272
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
NCT06218381
Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery
NCT06122805
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
NCT06360718
Iron Deficiency Anemia (IDA) and the Brain
NCT05929729
At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure
NCT06826534
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
NCT04536480
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
NCT05796687
Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA)
NCT05740254
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
NCT05218850
Clinical Decision Support Tool in PARDS Pilot Study
NCT04068012
Liquid Biopsies in Pediatric Solid Tumors
NCT05068583
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
NCT06195345
Childhood Outcomes of Preterm Brain Abnormalities
NCT03410810
RB Liquid Biopsy Biorepository
NCT04959097
LIFE Cancer Survivorship Database for Pediatric Cancer
NCT01518400
Bright IDEAS for Pediatric Palliative Care: A Problem-Solving Skills Intervention to Empower Parent Resilience
NCT05899998
Rapid Administration Pilot for Infusing Dinutuximab
NCT05421897
Enhancing BodyWorks: a Canine Health Literacy Module
NCT04516252
Fluoxetine vs CBT in Childhood Anxiety Disorders
NCT04760275
A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab
NCT04205175
The Gut-Brain Study
NCT03426826
Long Term Follow up of Children Enrolled in the REDvent Study
NCT03709199
Filipino Family Health Initiative
NCT04031170
Adaptive Cell Phone Support (ACPS)
NCT07064824
Crisis Interventions for Pediatric Providers - Autism Version
NCT07508436
Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer
NCT07630831
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
NCT06934655
Postoperative Steroid Use in Adolescent Idiopathic Scoliosis and Neuromuscular Scoliosis Patients
NCT06023043
Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4
NCT07103616
The Role of Timed Awakening in Treatment of Enuresis
NCT06586476
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 7 |
| Phase 3 | 3 |
| Phase 4 | 5 |
What is open in the Children's Hospital Los Angeles pipeline
35 recruiting of 119 indexed (29% open); 62 completed (52%).
Phase mix: 8 late (III/IV) vs 20 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Hospital Los Angeles: open-pipeline peers nationwide
Peers matched on 119 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Children's Hospital Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 119 trials (± recruiting share)
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
- Michigan State University · 120 trials · 20% recruiting
- San Diego State University · 118 trials · 27% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Natural Immune Systems · 29% recruiting · 17 trials
- Ono Pharmaceutical Co. · 29% recruiting · 17 trials
- Queen's Medical Center · 29% recruiting · 17 trials
- Inova Health Care Services · 29% recruiting · 75 trials
Related
What to do with this Children's Hospital Los Angeles page
119 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Los Angeles or any single study.
- 35 of Children's Hospital Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Children's Hospital Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Children's Hospital Los Angeles pipeline card: 119 registered trials from official public datasets.Report a data error.